NCT06292845 Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents
| NCT ID | NCT06292845 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Solid Tumor, Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-01-16 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-01-16 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a proof-of-principle study, that uses freshly resected human solid tumor specimens to assess the performance of topically applied fluorescent imaging agents for the detection of tumor tissue and close / tumor-positive resection margins ex vivo. Surgery will be performed in conformity with hospital protocol. The study will not interfere with the standard clinical care.
Eligibility Criteria
Inclusion Criteria: 1. Patients with a biopsy-proven solid tumor, scheduled for surgery at the Erasmus Medical Center. 2. Signed and dated informed consent obtained before any study-related procedure is performed. Exclusion Criteria: 1. Terminated surgical procedure. 2. No fresh specimen available. 3. Participation in a clinical trial for which the patient receives another fluorophore perioperatively.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06292845 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Solid Tumor, Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06292845 currently recruiting?
Yes, NCT06292845 is actively recruiting participants. Contact the research team at s.keereweer@erasmusmc.nl for enrollment information.
Where is the NCT06292845 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT06292845 clinical trial?
NCT06292845 is sponsored by Erasmus Medical Center. The trial plans to enroll 200 participants.